样式: 排序: IF: - GO 导出 标记为已读
-
Scanning the imaging horizon for hypertrophic cardiomyopathy Can. J. Cardiol. (IF 6.2) Pub Date : 2024-03-10 Andrew M. Crean MRCP FRCR FSCMR MPH
This paper discusses some of the recent advances in the use of noninvasive imaging applied to patients with hypertrophic cardiomyopathy. Echocardiography and cardiac CT are briefly discussed with respect to their power to detect apical aneurysmal disease. Echo phenotype-genotype correlations and the ability of echo to characterize myocardial work are reviewed. Positron emission tomography (PET) is
-
Rejuvenation of the Aging Heart: Molecular Determinants and Applications Can. J. Cardiol. (IF 6.2) Pub Date : 2024-03-07 Faisal J. Alibhai PhD, Ren-Ke Li MD PhD
In Canada and worldwide, the elderly population (i.e., individuals >65 years of age) is increasing disproportionately relative to the total population. This is expected to have a substantial impact on the healthcare system, as increased aged is associated with a greater incidence of chronic non-communicable diseases. Within the elderly population cardiovascular disease is a leading cause of death,
-
Preclinical studies on the impacts of frailty in the aging heart Can. J. Cardiol. (IF 6.2) Pub Date : 2024-03-07 Robert A. Rose PhD, Susan E. Howlett PhD
Age is a major risk factor for the development of cardiovascular diseases in men and in women. However, not all people age at the same rate and those who are aging rapidly are considered frail, when compared to their fit counterparts. Frailty is an important clinical challenge because those who are frail are more likely to develop and die from illnesses, including cardiovascular diseases, than fit
-
Current Use of Simulation in Canadian Cardiology Residency Programs: Painting the Landscape to Better Visualize the Future Can. J. Cardiol. (IF 6.2) Pub Date : 2024-03-07 Maria Fadous MD MHPE, Annabel A. Chen-Tournoux MD, Walter Eppich MD PhD
Simulation-based medical education (SBME) has been proposed as a method to expose cardiology residents to common and uncommon clinical scenarios. This approach aims to develop the core clinical competencies required for practice amidst many constraints, such as reduced training hours, limited patient encounters, and increased healthcare complexity. SBME fits particularly well in the Canadian Competency-by-Design
-
The diagnostic and therapeutic implications of phenocopies and mimics of Hypertrophic Cardiomyopathy Can. J. Cardiol. (IF 6.2) Pub Date : 2024-03-04 Athanasios Bakalakos, Emanuele Monda, Perry Mark Elliott
Hypertrophic cardiomyopathy (HCM) is a common myocardial disease defined by increased left ventricular wall thickness unexplained by loading conditions. It is frequently caused by pathogenic variants in sarcomeric protein genes, but several other syndromic, metabolic, infiltrative, and neuromuscular diseases can result in HCM phenocopies. This review summarizes the current understanding of these HCM
-
Association between prosthesis-patient mismatch and valve thrombosis: an independent link? Can. J. Cardiol. (IF 6.2) Pub Date : 2024-03-02 Antonin Trimaille MD MSc, Adrien Carmona MD, Shinnosuke Kikuchi MD, Manh Cuong Vu MD, Kensuke Matsushita MD PhD, Benjamin Marchandot MD, Olivier Morel MD PhD
-
Are we implanting too many primary prevention implantable cardioverter defibrillators? Can. J. Cardiol. (IF 6.2) Pub Date : 2024-03-01 Lebei Pi, Allan Skanes, Robert McKelvie
Canadian Cardiovascular Society/Canadian Heart Failure Society guidelines recommend optimizing patients with heart failure with reduced ejection fraction (HFrEF) on guideline directed medical therapy (GDMT) prior to implanting primary prevention implantable cardioverter defibrillators (ICDs). However, often GDMT is suboptimal at the time of ICD implantation, and is associated with reduced survival
-
Coexistent HCN4 and GATA5 rare variants and Atrial Fibrillation in a large Spanish Family Can. J. Cardiol. (IF 6.2) Pub Date : 2024-03-01 Alfonso Fraile, Jorge Cebrián, Israel Thuissard-Vasallo, Sara Pérez-Martín, Raquel Casado, Belen Gil-Fournier, Joaquín Alonso-Martín, Juan Tamargo, Ricardo Caballero, Eva Delpón, Francisco G. Cosío
Familial association of atrial fibrillation (AF) can involve single gene variants related to known arrhythmogenic mechanisms; however, genome-wide association studies often disclose complex genetic variants in familial and non-familial AF, making it difficult to relate to known pathogenetic mechanisms. The finding of 4 siblings with AF led to studying 47 members of a family. Long-term Holter monitoring
-
Small molecule inhibition for RASopathy-associated hypertrophic cardiomyopathy: Clinical application of a basic concept Can. J. Cardiol. (IF 6.2) Pub Date : 2024-03-01 Dominic Chaput, Gregor Andelfinger
The term RASopathies designates a group of developmental syndrome that are caused by activating variants of the RAS/MAPK cascade. The most prevalent clinical diagnosis is Noonan syndrome, and other, less prevalent conditions include Noonan syndrome with multiple lentigines, Costello syndrome, cardiofaciocutaneous syndrome, and others. Hypertrophic cardiomyopathy occurs in 10 % of these patients and
-
Restrictive vs Liberal Blood Transfusions for Patients with Acute Myocardial Infarction and Anaemia by Heart Failure Status: An RCT Subgroup Analysis Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-24 Gregory Ducrocq, Marine Cachanado, Tabassome Simon, Etienne Puymirat, Gilles Lemesle, Benoit Lattuca, Albert Ariza-Solé, Johanne Silvain, Emile Ferrari, Jose R. Gonzalez-Juanatey, Manuel Martínez-Sellés, Thibault Lermusier, Pierre Coste, Gerald Vanzetto, Yves Cottin, Jean G. Dillinger, Gonzalo Calvo, Philippe Gabriel Steg
Red blood cell transfusion can cause fluid overload. We evaluated the interaction between heart failure (HF) at baseline and transfusion strategy on outcomes in acute myocardial infarction (AMI). We used data from the randomized REALITY trial (https://www.clinicaltrials.gov/study/NCT02648113), comparing restrictive versus liberal transfusion strategies in patients with AMI and anaemia. HF was defined
-
Real-world treatment of in-stent restenosis: the return of the balloon Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-23 Alain Rivard
-
Influence of Temporal Trends of Learning Curves in Transcatheter Paravalvular Closure Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-23 Koray Çiloğlu, Ahmet Güner, Fatih Uzun, Mehmet Ertürk
-
Right heart reserve function assessed with fluid loading predicts late right heart failure after left ventricular assist device implantation. Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-23 Masaki Tsuji, Takahiro Kurihara, Yoshitaka Isotani, Chie Bujo, Junichi Ishida, Eisuke Amiya, Masaru Hatano, Asako Shimada, Hiroko Imai, Mitsutoshi Kimura, Shogo Shimada, Masahiko Ando, Minoru Ono, Issei Komuro
A left ventricular assist device (LVAD) is an effective therapeutic option for advanced heart failure. Late right heart failure (LRHF) is a complication after LVAD implantation associated with increasing morbidity and mortality; however, the assessment of right heart function, including right heart reserve function after LVAD implantation, has not been established. We focused on a fluid loading test
-
Determinants, Prevention, and Incidence of Cardiovascular Disease Among Immigrant and Refugee Populations Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-21 Manav V. Vyas, Vanessa Redditt, Sebat Mohamed, Mosana Abraha, Javal Sheth, Baiju R. Shah, Dennis T. Ko, Calvin Ke
-
Addressing Social Determinants of Health in Maternal Cardiovascular Health Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-20 Adhya Mehta, Jared Spitz, Sneha Sharma, Jason Bonomo, LaPrincess C. Brewer, Laxmi S. Mehta, Garima Sharma
-
First In-Human Use of a Novel Perfusion Balloon Catheter in the Management of Coronary Perforation Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-18 Vincent Siu, Shane Parfrey, Christopher Li, John J. Graham, Harindra C. Wijeysundera, Akshay Bagai, Jeffrey Pang, Sanjog Kalra, Vladimír Džavík, Rahul Bhindi, Christopher B. Overgaard, Ram Vijayaraghavan
Coronary perforation is a rare but potentially life-threatening complication of percutaneous coronary intervention. It can occur due to guide wire exit, high-pressure balloon/stent inflation, balloon/stent oversizing or rupture, or the use of atheroablative devices(1). Management with prolonged balloon inflation can lead to significant ischemia. We present the first in-human use of a unique perfusion
-
Therapy in Pediatric Pulmonary Hypertension: Memoir of an Unfinished Journey Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-17 Martin Hosking MD, Angela Bates MD
-
A Simple Score to Predict New-onset Atrial Fibrillation After Ablation of Typical Atrial Flutter Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-16 Zhoushan Gu, Jincheng Jiao, Youmei Shen, Xiangwei Ding, Chao Zhu, Mingfang Li, Hongwu Chen, Weizhu Ju, Kai Gu, Gang Yang, Hailei Liu, Pipin Kojodjojo, Minglong Chen
New-onset atrial fibrillation (NeAF) is common after cavotricuspid isthmus-dependent counterclockwise atrial flutter (CCW-AFL) ablation. This study aimed to investigate a simple predictive model of NeAF after CCW-AFL ablation. From January 2013 to December 2017, consecutive patients receiving CCW-AFL ablation were enrolled from three centers. Clinical, echocardiographic, and electrocardiographic data
-
Causal Inference Challenges in the Relationship Between Social Determinants and Cardiovascular Outcomes Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-15 Jay S. Kaufman
-
A new scoring system predicting side branch occlusion in patients undergoing left main bifurcation intervention: the LM V-RESOLVE score Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-13 Jining He, Zhongxing Cai, Hao-Yu Wang, Rui Zhang, Zhihao Zheng, Min Yang, Bo Xu, Kefei Dou
The risk of side branch (SB) occlusion is pivotal for decision-making of stenting strategies during unprotected left main (LM) bifurcation percutaneous coronary intervention (PCI). Accordingly, this study aimed to develop a scoring system for predicting SB occlusion during unprotected LM bifurcation PCI. A total of 855 consecutive patients undergoing unprotected LM bifurcation PCI with provisional
-
Risks and benefits of intermittent fasting for the aging cardiovascular system Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-12 Mualla Ozcan, Mahmoud Abdellatif, Ali Javaheri, Simon Sedej
Population aging and the associated increase in cardiovascular disease rates pose serious threats to global public health. Different forms of fasting have become an increasingly attractive strategy to directly address aging and potentially limit or delay the onset of cardiovascular diseases. A growing number of experimental studies and clinical trials indicate that the amount and timing of food intake
-
Atrial Fibrillation in The Emergency Department: More Than “Meet 'Em, Treat 'Em, And Street 'Em” Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-10 Jason G. Andrade, Laurent Macle
-
Sex-Specific Cardiometabolic Determinants of Postoperative Atrial Fibrillation After Cardiac Surgery Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-09 Amélie Paquin, Pierre Voisine, Paul Poirier, Marie-Annick Clavel, Sarah O’Connor, Jeanne Roberge, Marie-Eve Piché
Cardiometabolic diseases increase the risk of postoperative atrial fibrillation (POAF), a complication leading to higher long-term risk of major cardiovascular events (MACE). It remains unknown whether the impact of these risk factors differs according to sex. We sought to evaluate the sex-specific predictors of POAF after coronary artery bypass grafting (CABG). In a prospective registry of patients
-
A Standardized Classification for the Various Total Arch Replacement Techniques. See the Benchmarks, Then Raise the Bar. Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-09 R. Scott McClure
-
Race and Ethnicity Research in Cardiovascular Disease in Canada: Challenges and Opportunities Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-09 Saswata Deb, Maneesh Sud, Natalie Coburn, Angela Jerath, Mehras Motamed, Baiju Shah, Javal Sheth, Dennis T. Ko
Even though Canada is one of the most culturally diverse countries in the world, offering universal healthcare to all its citizens, the recent COVID-19 pandemic has exposed significant health inequities in our healthcare system. We continue to face challenges ensuring health equity in cardiovascular diseases. Persistent outcome disparities may be driven by race and ethnicity-based differences in healthcare
-
Canadian Society of Clinical Chemists Harmonized Pediatric Lipid Reporting Recommendations for Clinical Laboratories Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-08 Victoria Higgins, Nicole M.A. White-Al Habeeb, Dana Bailey, Daniel R. Beriault, Ivan M. Blasutig, Christine P. Collier, Allison A. Venner, Khosrow Adeli
-
RAFF-5 Study to improve the quality and safety of care for patients seen in the emergency department with acute atrial fibrillation and flutter Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-07 Ian G. Stiell, Monica Taljaard, Rob Beanlands, Christopher Johnson, Mehrdad Golian, Martin Green, Edmund Kwok, Erica Brown, Marie-Joe Nemnom, Debra Eagles
We sought to improve the immediate and subsequent care of ED patients with acute atrial fibrillation (AF) and flutter (AFL) by implementing the principles of the CAEP AF/AFL Best Practices Checklist. This cohort study included three periods: before (7 months), intervention introduction (1 month), and after (7 months), and was conducted at a major academic centre. We included patients presenting with
-
Vascular Aging in Women Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-06 Maria Agustina Lopez Laporte, Thais Coutinho
Well-established cardio-metabolic and sex-specific risk factors impact vascular health across a woman’s lifespan and modulate lifelong risk for cardiovascular disease (CVD), which remains the number one killer of women worldwide. CVD remains under-studied and under-recognized in women. In this brief review, we describe the process of vascular aging, highlighting the impact of biological female sex
-
The AMDS Stent Reduces Postoperative Distal Anastomotic New Re-Entry (DANE) Tears, But Will It Reduce the Need for Late Aortic Reintervention? Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-03 Kendall M. Lawrence, Nimesh Desai
Abstract not available
-
Myosin Inhibitors for Hypertrophic Obstructive Cardiomyopathy (HOCM): Is HOCM passing another Crossroad? Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-03 Thorsten Lawrenz, Dennis Lawin, Christoph Stellbrink
Abstract not available
-
Pulmonary vein isolation in elderly patients ≥ 75 years: a propensity-score matched analysis with focus on differences between atrial fibrillation types Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-01 Andreas A. Boehmer, Moritz Rothe, Christoph Keim, Elena Nussbaum, Lilli C. Wiedenmann, Katia Y. Schneider, Pascal Spork, Christian Ruckes, Bianca C. Dobre, Bernhard M. Kaess, Joachim R. Ehrlich
Background Age is a major risk factor for development of atrial fibrillation (AF) and associated with increased recurrence rates in the setting of rhythm control. Current data tend to support catheter ablation in elderly patients but uncertainties exist regarding efficacy and safety of ablation in elderly patients. Methods Prospective, single-center observational study with propensity score matching
-
HOW TO ASSESS FRAILTY IN PRECLINICAL MODELS AND RELATE IT TO CLINICAL PARADIGMS Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-02 Susan E. Howlett
Frailty is a state of increased risk for adverse health outcomes. Their degree of frailty makes frail individuals more susceptible to cardiovascular disease and mortality than are their fitter counterparts. Frailty can be quantified clinically in various ways. Most common are the frailty phenotype and frailty index. These have been reverse-translated for use in aging mice. This review describes these
-
Mitral Transcatheter Edge-to-Edge Repair in Nonagenarians Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-02 Alon Shechter, Tarun Chakravarty, Ran Kornowski, Danon Kaewkes, Vivek Patel, Homa Taheri, Takashi Nagasaka, Ofir Koren, Keita Koseki, Sabah Skaf, Moody Makar, Raj R. Makkar, Robert J. Siegel
-
Racial and ethnic disparities in primary prevention of cardiovascular disease Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-02 Mohammad R. Ali, Hadjer Nacer, Claire A. Lawson, Kamlesh Khunti
-
The dynamic nature of the socioeconomic determinants of cardiovascular health: A narrative review Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-02 David A. Alter, Peter C. Austin, Aaron Rosenfeld
Despite decades of social epidemiologic research, health inequities remain pervasive and ubiquitous in Canada and elsewhere. One reason may be our use of socioeconomic measurement, which have often relied on single point-in-time exposures.
-
Geographical variations in the effectiveness and safety of abbreviated or standard antiplatelet therapy after PCI in patients at high bleeding risk Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-02 Yukio Ozaki, Sung-Jin Hong, Dik Heg, Enrico Frigoli, Pascal Vranckx, Marie-Claude Morice, Bernard Chevalier, Yoshinobu Onuma, Stephan Windecker, Maurizio Di Biasi, Robert Whitbourn, Dariusz Dudek, Owen Christopher Raffel, Kiyokazu Shimizu, Paolo Calabrò, Ole Fröbert, Fernando Cura, Jurrien ten Berg, Pieter C. Smits, Marco Valgimigli
Abstract not available
-
Impact of Fontan fenestration on adverse cardiovascular outcomes: a multicenter study Can. J. Cardiol. (IF 6.2) Pub Date : 2024-02-02 Dib Nabil, Michelle Samuel, Sylvie Levesque, Ali Zaidi, Sarah Cohen, Alexander R. Opotowsky, François-Pierre Mongeon, Blandine Mondésert, Joseph Kay, Reda Ibrahim, Robert M. Hamilton, Anne Fournier, Susan M. Jameson, Annie Dore, Stephen C. Cook, Scott Cohen, Marie-A Chaix, Craig S. Broberg, Jamil Aboulhosn, Nancy Poirier, Paul Khairy
-
From atrial fibrillation management to atrial myopathy assessment: the evolving concept of left atrium disease in hypertrophic cardiomyopathy Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-28 Carlo Fumagalli, Chiara Zocchi, Michele Ciabatti, Alessandra Milazzo, Francesco Cappelli, Stefano Fumagalli, Maurizio Pieroni, Iacopo Olivotto
-
Knowledge translation and systems transformation needed: Improving timely and equitable access to innovations in heart valve disease Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-26 Sandra B. Lauck, Tej Sheth, Erin Tang, David Wood
Abstract not available
-
The Revolution of Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-26 Rebecca Haraf, Hany Habib, Ahmad Masri
-
Association between acute myocardial infarction symptoms and short- and long-term mortality after the event. Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-24 Timo Schmitz, Eva Harmel, Philip Raake P, Dennis Freuer, Inge Kirchberger, Margit Heier, Annette Peters, Jakob Linseisen, Christa Meisinger
-
A New Era in Aortic Arch Repair: The Breakthrough of the Unibody Triple-Branched Stent graft Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-24 Chao Song, Bowen Liang, Qingsheng Lu
Abstract not available
-
What Should You Do When You Find Atrial Fibrillation on an Implanted Pacemaker or Defibrillator? It’s More Than You Think… Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-26 Jeff S. Healey MD, Jorge A. Wong MD PhD
Abstract not available
-
Should Rotational Atherectomy Be Used More Often in STEMI to Treat Calcified Culprit Lesions? Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-24 Gemina Doolub MD, Hung Q. Ly MD SM, Guillaume Marquis-Gravel MD MSc
Abstract not available
-
Centering Equity in Cardiovascular Health Technology Assessment Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-20 Dominique Vervoort, Aminah Sallam, Stephen E. Fremes, Harindra C. Wijeysundera, Derrick Y. Tam
Abstract not available
-
Socioeconomic determinants of health: remoteness from care Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-19 Luke Eckersley
Remoteness from care remains a major challenge to equitable provision of health services worldwide. Beyond the difficulties associated with geographically and climatically rugged terrain, there are also socioeconomic, cultural and technological challenges associated with remote residence. The objective of this review is to examine the factors whereby remoteness can be associated with sociodemographic
-
Reply to Pendyal, A.—Long-term Adverse Outcomes in Black Women With Obstructive Coronary Artery Disease: A Study of the Women’s Ischemia Syndrome Evaluation (WISE) Cohort. Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-18 Judy M. Luu, C. Noel Bairey Merz, Janet Wei
Abstract not available
-
Unique Aspects of Hypertrophic Cardiomyopathy in Children Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-18 Madeleine Townsend, Aamir Jeewa, Michael Khoury, Chentel Cunningham, Kristen George, Jennifer Conway
-
Decoding Long Noncoding RNAs in Myocardial Infarction: A Step Closer to a "Magic Bullet"? Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-21 Aaron M. Johnston BA, Chi Him Kendrick Yiu BSc MRes, Svetlana Reilly MBBS MD DPhil
Abstract not available
-
Infected pseudoaneurysm of an outflow graft after left ventricular assist device insertion Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-20 Nicole L. Fung, Derrick Y. Tam, Rashmi Nedadur, Terrence M. Yau
Bleeding and infection may complicate LVAD implantation. We present the case of a patient with recurrent fevers after LVAD implantation who was found to have an infected pseudoaneurysm of the outflow graft at the graft-aortic anastomosis, with successful surgical intervention. Patients with infected pseudoaneurysms post LVAD insertion require urgent surgical intervention that may differ from that for
-
Intravascular lithotripsy-facilitated balloon-assisted subintimal entry for chronic total occlusion percutaneous coronary intervention Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-18 Lorenzo Azzalini, Kathleen E. Kearney, William L. Lombardi
Severely calcified chronic total occlusions (CTO) are particularly challenging to recanalize with a conventional wiring approach. Balloon-assisted subintimal entry (BASE) is an effective option to get access to the extraplaque space and set up for antegrade dissection/re-entry. However, conventional balloons are sometimes unable to dissect the vessel due to severe calcification, and alternative solutions
-
Emerging Themes in Genetics of Hypertrophic Cardiomyopathy. Current status and clinical application. Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-18 Soledad García-Hernández, Luis de la Higuera Romero, Juan Pablo Ochoa, William J. McKenna
-
Outcomes of Focal Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-17 Caijie Shen, Xianfeng Du, Jiating Dai, Mingjun Feng, Yibo Yu, Jing Liu, Guohua Fu, Binhao Wang, Yongxing Jiang, He Jin, Huimin Chu
-
Very Late Stent Thrombosis in Japan – A Look into the Future? Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-13 Brian K. Courtney
Abstract not available
-
Outcomes of Total Aortic Arch Replacement in a Canadian Nationwide Registry Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-12 Julia F. Chen, Maral Ouzounian, Mark Peterson, Mark Tatangelo, Francois Dagenais, Ali Hage, Thomas F. Lindsay, Michael W.A. Chu, Jennifer Chung
Background Accurate benchmarking of outcomes following elective open total arch replacement is important for surgical decision-making and for comparisons to emerging endovascular technologies. Methods A multicenter registry of consecutive aortic arch procedures in 9 centers across Canada contained 250 elective total arch replacements from 2010 to 2021. A total of 728 patients undergoing elective hemiarch
-
Complex High-risk Percutaneous Coronary Intervention Types, Trends, and Outcomes in Non-surgical Centres Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-11 Warkaa Shamkhani, Muhammad Rashid, Saadiq Moledina, Peter Ludman, Nick Curzen, Harindra C. Wijeysundera, Cindy L. Grines, Mamas A. Mamas
-
Restarting anticoagulation after major bleeding in patients with atrial fibrillation Can. J. Cardiol. (IF 6.2) Pub Date : 2024-01-11 Stephanie Carlin, John Eikelboom
Abstract not available
-
-
-